Skip to main content

Table 1 Characteristics of the population.

From: Clinical outcome of empiric antimicrobial therapy of bacteremia due to extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae

FACTOR CASE FATALITY WITH
FACTOR
CASE FATALITY WITHOUT
FACTOR
RELATIVE RISK
(95% CI)
  P-VALUE
Male 6/44 (14%) 10/35 (29%) 0.48 (0.19-1.19)   0.09
Charlson ≥ median(4)
(Age Adjusted)
12/45 (27%) 4/34 (12%) 2.27 (0.80-6.41)   0.09
Cerebrovascular Disease 1/3 (33%) 15/76 (20%) 1.69 (0.32-8.91)   NS
Congestive Heart Failure 1/7 (14%) 15/72 (21%) 0.69 (0.11-4.45)   NS
Chronic Pulmonary Disease 0/1 (0%) 16/78 (21%) 0.00()   NS
Dementia 1/4 (25%) 15/75 (20%) 1.25 (0.22-7.24)   NS
Diabetes without complications 0/9 (0%) 16/70 (23%) 0.00()   NS
Diabetes with complications 1/10 (10%) 15/69 (22%) 0.46 (0.07-3.11)   NS
Paraplegia 0/1 (0%) 16/78 (21%) 0.00()   NS
Mild Liver Disease 3/4 (75%) 13/75 (17%) 4.32 (2.04-9.17)   0.03
Severe Liver Disease 2/4 (50%) 14/75 (19%) 2.68 (0.90-7.95)   NS
Malignancy 5/21 (24%) 11/58 (19%) 1.25 (0.49-3.19)   NS
Metastatic 0/1 (0%) 16/78 (21%) 0.00()   NS
Myocardial Infarction 1/3 (33%) 15/76 (20%) 1.69 (0.32-8.91)   NS
Peripheral Vascular Disease 0/1 (0%) 16/78 (21%) 0.00()   NS
Peptic Ulcer Disease 0/2 (0%) 16/77 (21%) 0.00()   NS
Rheumatologic 2/4 (50%) 14/75 (19%) 2.68 (0.90-7.95)   NS
Renal 5/19 (26%) 11/60 (18%) 1.43 (0.57-3.61)   NS
Dialysis 2/5 (40%) 14/74 (19%) 2.11 (0.65-6.83)   NS
\